Literature DB >> 9326630

Cleft palate in mice with a targeted mutation in the gamma-aminobutyric acid-producing enzyme glutamic acid decarboxylase 67.

B G Condie1, G Bain, D I Gottlieb, M R Capecchi.   

Abstract

The functions of neurotransmitters in fetal development are poorly understood. Genetic observations have suggested a role for the inhibitory amino acid neurotransmitter gamma-aminobutyric acid (GABA) in the normal development of the mouse palate. Mice homozygous for mutations in the beta-3 GABAA receptor subunit develop a cleft secondary palate. GABA, the ligand for this receptor, is synthesized by the enzyme glutamic acid decarboxylase. We have disrupted one of the two mouse Gad genes by gene targeting and also find defects in the formation of the palate. The striking similarity in phenotype between the receptor and ligand mutations clearly demonstrates a role for GABA signaling in normal palate development.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9326630      PMCID: PMC23502          DOI: 10.1073/pnas.94.21.11451

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  27 in total

Review 1.  gamma-Aminobutyric acid outside the mammalian brain.

Authors:  S L Erdö; J R Wolff
Journal:  J Neurochem       Date:  1990-02       Impact factor: 5.372

2.  GABA and glutamate depolarize cortical progenitor cells and inhibit DNA synthesis.

Authors:  J J LoTurco; D F Owens; M J Heath; M B Davis; A R Kriegstein
Journal:  Neuron       Date:  1995-12       Impact factor: 17.173

3.  Involvement of GABAA receptors in the outgrowth of cultured hippocampal neurons.

Authors:  G Barbin; H Pollard; J L Gaïarsa; Y Ben-Ari
Journal:  Neurosci Lett       Date:  1993-04-02       Impact factor: 3.046

4.  Letter: Association between maternal intake of diazepam and oral clefts.

Authors:  D Aarskog
Journal:  Lancet       Date:  1975-11-08       Impact factor: 79.321

5.  GABAA receptors mediate trophic effects of GABA on embryonic brainstem monoamine neurons in vitro.

Authors:  J Liu; A L Morrow; L Devaud; D R Grayson; J M Lauder
Journal:  J Neurosci       Date:  1997-04-01       Impact factor: 6.167

6.  Glucose-inhibition of glucagon secretion involves activation of GABAA-receptor chloride channels.

Authors:  P Rorsman; P O Berggren; K Bokvist; H Ericson; H Möhler; C G Ostenson; P A Smith
Journal:  Nature       Date:  1989-09-21       Impact factor: 49.962

7.  Association between cleft lip with or without cleft palate and prenatal exposure to diazepam.

Authors:  M J Safra; G P Oakley
Journal:  Lancet       Date:  1975-09-13       Impact factor: 79.321

8.  Lack of relation of oral clefts to diazepam use during pregnancy.

Authors:  L Rosenberg; A A Mitchell; J L Parsells; H Pashayan; C Louik; S Shapiro
Journal:  N Engl J Med       Date:  1983-11-24       Impact factor: 91.245

9.  Derivation of completely cell culture-derived mice from early-passage embryonic stem cells.

Authors:  A Nagy; J Rossant; R Nagy; W Abramow-Newerly; J C Roder
Journal:  Proc Natl Acad Sci U S A       Date:  1993-09-15       Impact factor: 11.205

10.  GABA and pancreatic beta-cells: colocalization of glutamic acid decarboxylase (GAD) and GABA with synaptic-like microvesicles suggests their role in GABA storage and secretion.

Authors:  A Reetz; M Solimena; M Matteoli; F Folli; K Takei; P De Camilli
Journal:  EMBO J       Date:  1991-05       Impact factor: 11.598

View more
  53 in total

Review 1.  GABAergic interneuron origin of schizophrenia pathophysiology.

Authors:  Kazu Nakazawa; Veronika Zsiros; Zhihong Jiang; Kazuhito Nakao; Stefan Kolata; Shuqin Zhang; Juan E Belforte
Journal:  Neuropharmacology       Date:  2011-01-26       Impact factor: 5.250

Review 2.  Vesicular and plasma membrane transporters for neurotransmitters.

Authors:  Randy D Blakely; Robert H Edwards
Journal:  Cold Spring Harb Perspect Biol       Date:  2012-02-01       Impact factor: 10.005

3.  DNA methyltransferases1 (DNMT1) and 3a (DNMT3a) colocalize with GAD67-positive neurons in the GAD67-GFP mouse brain.

Authors:  Bashkim Kadriu; Alessandro Guidotti; Ying Chen; Dennis R Grayson
Journal:  J Comp Neurol       Date:  2012-06-15       Impact factor: 3.215

Review 4.  Pharmacological and biochemical aspects of GABAergic neurotransmission: pathological and neuropsychobiological relationships.

Authors:  Renê Oliveira Beleboni; Ruither Oliveira Gomes Carolino; Andrea Baldocchi Pizzo; Lissandra Castellan-Baldan; Joaquim Coutinho-Netto; Wagner Ferreira dos Santos; Norberto Cysne Coimbra
Journal:  Cell Mol Neurobiol       Date:  2004-12       Impact factor: 5.046

Review 5.  Orofacial clefting: recent insights into a complex trait.

Authors:  Astanand Jugessur; Jeffrey C Murray
Journal:  Curr Opin Genet Dev       Date:  2005-06       Impact factor: 5.578

6.  Retinoic acid, GABA-ergic, and TGF-beta signaling systems are involved in human cleft palate fibroblast phenotype.

Authors:  Tiziano Baroni; Catia Bellucci; Cinzia Lilli; Furio Pezzetti; Francesco Carinci; Ennio Becchetti; Paolo Carinci; Giordano Stabellini; Mario Calvitti; Eleonora Lumare; Maria Bodo
Journal:  Mol Med       Date:  2006 Sep-Oct       Impact factor: 6.354

7.  Local GABA circuit control of experience-dependent plasticity in developing visual cortex.

Authors:  T K Hensch; M Fagiolini; N Mataga; M P Stryker; S Baekkeskov; S F Kash
Journal:  Science       Date:  1998-11-20       Impact factor: 47.728

8.  Increased anxiety and altered responses to anxiolytics in mice deficient in the 65-kDa isoform of glutamic acid decarboxylase.

Authors:  S F Kash; L H Tecott; C Hodge; S Baekkeskov
Journal:  Proc Natl Acad Sci U S A       Date:  1999-02-16       Impact factor: 11.205

9.  Cleft palate is caused by CNS dysfunction in Gad1 and Viaat knockout mice.

Authors:  Won-Jong Oh; Joby J Westmoreland; Ryan Summers; Brian G Condie
Journal:  PLoS One       Date:  2010-03-19       Impact factor: 3.240

10.  Current concepts in genetics of nonsyndromic clefts.

Authors:  Jyotsna Murthy; Lvks Bhaskar
Journal:  Indian J Plast Surg       Date:  2009 Jan-Jun
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.